Merck & Co., Inc.
MRK
$87.37
$1.291.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 4.43B | 5.08B | 3.74B | 3.16B | 5.46B |
Total Depreciation and Amortization | 1.06B | 1.06B | 1.11B | 1.15B | 1.07B |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 61.00M | 75.00M | 448.00M | 2.41B | 128.00M |
Change in Net Operating Assets | -2.26B | -3.71B | -1.86B | 2.58B | -1.01B |
Cash from Operations | 3.29B | 2.50B | 3.45B | 9.29B | 5.64B |
Capital Expenditure | -764.00M | -1.33B | -937.00M | -783.00M | -791.00M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -2.00M | -3.35B | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -6.00M | -159.00M | -505.00M | 283.00M | -278.00M |
Cash from Investing | -770.00M | -1.49B | -1.44B | -3.85B | -1.07B |
Total Debt Issued | 48.00M | -- | 0.00 | -1.00M | 3.60B |
Total Debt Repaid | 0.00 | -2.50B | -539.00M | 0.00 | 0.00 |
Issuance of Common Stock | 12.00M | 19.00M | 12.00M | 5.00M | 73.00M |
Repurchase of Common Stock | -1.35B | -1.16B | -489.00M | -444.00M | -251.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -2.08B | -2.05B | -1.95B | -1.95B | -1.99B |
Other Financing Activities | -194.00M | -60.00M | -42.00M | -32.00M | -220.00M |
Cash from Financing | -3.56B | -5.76B | -3.01B | -2.43B | 1.22B |
Foreign Exchange rate Adjustments | 374.00M | 156.00M | -367.00M | 294.00M | -82.00M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -659.00M | -4.59B | -1.37B | 3.32B | 5.70B |